Long-term Study of DSP-5423P in Patients With Schizophrenia

Summary

The study evaluates the long term safety of DSP-5423P in patients with schizophrenia.

Timeline

Start

2014-12

Primary completion

2017-05

Completion

2017-05

Publications

• Iwata N, Ishigooka J, Naoi I, Matsumoto M, Kanamori Y, Nakamura H, Higuchi T. Long-Term Safety and Efficacy of Blonanserin Transdermal Patches in Japanese Patients with Schizophrenia: A 52-Week Open-Label, Multicenter Study. CNS Drugs. 2020 Jan;34(1):103-116. doi: 10.1007/s40263-019-00692-6.

Drugs

Indications